Form 4: Glen A. Taylor Reports Beneficial Ownership Changes in Envoy Medical, Inc.

Glen A. Taylor, a director and 10% owner of Envoy Medical, Inc., filed a Form 4 disclosing changes in beneficial ownership, including the acquisition of warrants and holdings through related entities.

Summary

• Glen A. Taylor, a director and 10% owner of Envoy Medical, Inc. (COCH), reported changes in beneficial ownership on February 27, 2024.
• The report details the acquisition of 500,000 warrants to purchase Class A Common Stock at $1.24 per share, exercisable from February 27, 2024, and expiring on February 26, 2026.
• Taylor directly owns 2,953,607 shares of Class A Common Stock.
• He also indirectly owns 2,526,058 shares of Class A Common Stock through Taylor Sports Group and 4,810,384 shares through GAT Funding, LLC.
• Additionally, GAT Funding LLC holds 1,000,000 shares of Class A Common Stock underlying Series A Preferred Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The insider is increasing their potential stake in the company through warrant acquisition, which could be interpreted as a sign of confidence. However, it's a standard filing and doesn't provide explicit forward-looking statements.

Positives

• The acquisition of warrants could indicate a positive outlook on the company's future performance, as Taylor is increasing his potential stake.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track changes in ownership and potential alignment of interests.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The warrant acquisition could be viewed positively by shareholders as it aligns the insider's interests with the company's success.

Key Dates